(326a) Biomimitic Hydrogels for Retinal Engineering
AIChE Annual Meeting
2022
2022 Annual Meeting
Materials Engineering and Sciences Division
Biomimetic Materials I
Tuesday, November 15, 2022 - 12:30pm to 1:06pm
Cell transplantation has been explored as a promising treatment for retinal degeneration. However, one major limitation to retinal cell transplantation is that the majority (>90%) of transplanted cells do not survive. It is not clear if the cells do not survive due to damage during injection or lack of favorable cues in the bolus injection microenvironment. We have explored the sources of damage to transplanted cells, and have also investigated whether a hydrogel carrier presenting specific chemical and physical cues may 1. Protect retinal cells from damage during transplantation, and 2. Promote retinal cell survival as well as migration and differentiation in the bolus transplantation environment. Alginate-based hydrogels of varying stiffness and chemical composition were explored using a design-of-experiments (DOE) to develop a set of hydrogel formulations. Specifically, the stiffness was controlled using cross-linking with calcium at varying concentration, such that it fell within the range reported for retinal tissue (~1 â 10kPa). Attachment ligands included RGDS peptides mimicking those present in fibronectin and other ECM proteins, as well as laminin and the glycosaminoglycans hyaluronic acid (HA) and chondroitin sulfate (CS). Novel in vitro models of subretinal cell injection and transplantation were developed to test the developed biomaterials. Preliminary data indicate a modest impact of biomaterial properties on cell survival, but a significant effect of chemical cues and stiffness on migration.